Safety and efficacy of salvage nano-particle albumin bound paclitaxel in recurrent cervical cancer: a feasibility study

BACKGROUND: After platinum and taxane chemotherapy, with or without bevacizumab, active regimens for advanced or recurrent cervical cancer are lacking. Our objective was to review a single institution experience in treating recurrent, refractory cervical cancer with nano-particle albumin bound (NAB)...

Descripción completa

Detalles Bibliográficos
Autores principales: Minion, Lindsey E., Chase, Dana M., Farley, John H., Willmott, Lyndsay J., Monk, Bradley J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4880945/
https://www.ncbi.nlm.nih.gov/pubmed/27231575
http://dx.doi.org/10.1186/s40661-016-0025-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4880945/
https://www.ncbi.nlm.nih.gov/pubmed/27231575
http://dx.doi.org/10.1186/s40661-016-0025-6

Ejemplares similares